Nuvectra Corporation

NVTRQ

US67075N1081

Medical Equipment, Supplies & Distribution

Delayed OTC Markets Other stock markets			5-day change	1st Jan Change
- ^USD	-.--%		+16.67%	-85.26%

2020	Nuvectra Corporation Went Out of Business	CI
2020	Second Amended Liquidation Plan Approved for Nuvectra Corporation	CI

Nuvectra Corporation Receives FDA Head-Only MR-Conditional Approval for Algovita

December 03, 2018 at 08:01 am

Nuvectra Corporation announced that it has received U.S. Food and Drug Administration (FDA) head-only MR-conditional approval for the Company’s Algovita SCS system.

Latest news about Nuvectra Corporation

Nuvectra Corporation Went Out of Business	20-06-02	CI
Second Amended Liquidation Plan Approved for Nuvectra Corporation	20-05-21	CI
Second Amended Liquidation Plan Filed by Nuvectra Corporation	20-05-18	CI
Motion for Asset Sale Approved for Nuvectra Corporation	20-03-09	CI
First Amended Disclosure Statement Approved for Nuvectra Corporation	20-03-06	CI
First Amended Liquidation Plan and Disclsoure Statement Filed by Nuvectra Corporation	20-03-05	CI
Notice of Selection of Successful Bidder Filed for Nuvectra Corporation	20-02-27	CI
Liquidation Plan and Disclosure Statement Filed by Nuvectra Corporation	20-01-28	CI
Bidding Procedure Approved for Nuvectra Corporation	20-01-12	CI
Motion for Asset Sale Filed by Nuvectra Corporation	19-12-19	CI
Nuvectra Corporation Announces Reduction in Force; Announces Board Changes	19-11-22	CI
Nuvectra Corporation(NasdaqGM:NVTR) dropped from NASDAQ Composite Index	19-11-21	CI
Nuvectra Corporation(NasdaqGM:NVTR) dropped from S&P TMI Index	19-11-15	CI
Nuvectra Corporation Filed for Bankruptcy	19-11-12	CI
Nuvectra Corporation Submits Chemical Composition and Biocompatibility Data to FDA for Virtis	19-10-18	CI
Nuvectra Corporation(NasdaqGM:NVTR) dropped from S&P Global BMI Index	19-09-23	CI
Nuvectra Corporation Names Jennifer J. Kosharek as Executive Vice President and Chief Financial Officer, Effective September 16, 2019	19-09-20	CI
Nuvectra Explores Strategic Options	19-08-26	CI
Transcript : Nuvectra Corporation, Q2 2019 Earnings Call, Jul 31, 2019	19-07-31
Nuvectra Corporation Reports Earnings Results for the Second Quarter Ended June 30, 2019	19-07-31	CI
Nuvectra Corporation Revises Revenues Guidance for 2019	19-07-31	CI
Nuvectra Corporation Announces Resignation of J. Paul Hanchin as President	19-07-10	CI
Nuvectra Corporation Announces the Resignation of J. Paul Hanchin as President	19-06-28	CI
Nuvectra Corporation(OTCPK:NVTR.Q) dropped from Russell 2000 Dynamic Index	19-06-28	CI
Nuvectra Files Regulatory Submission with FDA for Algovita Full-Body MR-Conditional Approval	19-06-11	CI

Nuvectra Corporation is a neurostimulation company that focuses on helping physicians to improve the lives of people with chronic neurological conditions. The Company's Algovita Spinal Cord Stimulation (SCS) System (Algovita) is the Company's commercial offering and is Conformite Europeene (CE) marked and the United States Food and Drug Administration (FDA) approved for the treatment of chronic pain of the trunk and/or limbs. Its technology platform also has capabilities under development to support other neurological indications, such as sacral nerve stimulation (SNS) and deep brain stimulation (DBS). In addition, its NeuroNexus Technologies, Inc. (NeuroNexus) subsidiary designs, manufactures and markets neural-interface technologies for the neuroscience clinical research market. Its Virtis is an application of the Company's neurostimulation technology platform and its first product for the SNS market. Its subsidiaries include Algostim, LLC (Algostim) and PelviStim LLC (PelviStim).

Sector

Medical Equipment, Supplies & Distribution

More about the company

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
NUVECTRA CORPORATION	-85.26%	268K
ABBOTT LABORATORIES	-7.38%	181B
MEDTRONIC PLC	-0.46%	108B
BECTON, DICKINSON AND COMPANY	-6.98%	66.12B
DEXCOM, INC.	+2.65%	50.65B
CENCORA, INC.	+5.27%	43.11B
HOYA CORPORATION	+5.96%	40.74B
METTLER-TOLEDO INTERNATIONAL, INC.	+19.92%	31.6B
TERUMO CORPORATION	+15.69%	25.56B
WEST PHARMACEUTICAL SERVICES, INC.	-7.00%	24.16B

Other Medical Equipment, Supplies & Distribution